There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:C07K16/22
Jump to navigation
Jump to search
Pages in category "C07K16/22"
The following 11 pages are in this category, out of 11 total.
1
- 17415589. Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18359569. LDL RECEPTOR-DIRECTED BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18420510. ISOFORM-SELECTIVE ANTI-TGF-BETA ANTIBODIES AND METHODS OF USE simplified abstract (GENENTECH, INC.)
- 18550914. METHODS FOR TREATING GYNECOLOGIC CANCER USING COMBINATION THERAPY WITH ANTI-MUC16 x CD3 MULTISPECIFIC ANTIBODIES AND VEGF INHIBITORS simplified abstract (The General Hospital Corporation)
- 18559333. METHODS AND COMPOSITIONS THEREOF FOR SITE-SPECIFIC LABELING OF HUMAN IgG BY PROXIMITY-BASED SORTASE-MEDIATED LIGATION simplified abstract (The Trustees of the University of Pennsylvania)
- 18597797. ADAM6 MICE simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18637124. ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18663549. METHODS AND COMPOSITIONS COMPRISING A KRASG12C INHIBITOR AND A VEGF INHIBITOR FOR TREATING SOLID TUMORS simplified abstract (Genentech, Inc.)
- 18784586. NEUTRALIZING ANTIBODIES TO THE ALPHA V BETA 8 INTEGRIN COMPLEX FOR IMMUNOTHERAPY (The Regents of the University of California)
